Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge.
Liu Q, Zhao H, Li Z, Zhang Z, Huang R, Gu M, Zhuang K, Xiong Q, Chen X, Yu W, Qian S, Zhang Y, Tan X, Zhang M, Yu F, Guo M, Huang Z, Wang X, Xiang W, Wu B, Mei F, Cai K, Zhou L, Zhou L, Wu Y, Yan H, Cao S, Lan K, Chen Y.
Liu Q, et al. Among authors: zhuang k.
Signal Transduct Target Ther. 2023 Sep 14;8(1):347. doi: 10.1038/s41392-023-01615-0.
Signal Transduct Target Ther. 2023.
PMID: 37704615
Free PMC article.